In the realm of childhood health, ADHD—an abbreviation for attention-deficit/hyperactivity disorder—demands attention. This study explores ADHD's prevalence, diving deep into how often it's diagnosed, how severe it can be, and what treatment options children are receiving in the U.S. by analyzing data from the National Survey of Children's Health.

Using data from 2022, the research shines a spotlight on how ADHD presents across different demographics. It delves into the overlap of ADHD with other disorders, and evaluates the extent to which affected children receive medications or behavioral therapies. Such insights aim to foster better understanding and potential policy adjustments.

Researchers used data gathered from the 2022 National Survey of Children's Health, focusing on children aged 3-17. They assessed how many had ever been diagnosed with ADHD and how many currently have it.

They also investigated how severe ADHD was, how many kids had other disorders at the same time, and whether they received medication like Ritalin or therapy to help with symptoms.

Nearly 1 in 9 kids in the U.S., or 11.4%, have been diagnosed with ADHD. Currently, 10.5% have ADHD, with more than half experiencing moderate to severe symptoms.

Three quarters of these kids deal with another disorder as well. Just over half receive medication like Adderall or Vyvanse, and about 44% get behavioral therapy. Yet, around a third don't receive any treatment at all specifically for ADHD.

ADHD in children continues to be a growing issue in public health. Since 2016, around a million more kids have been diagnosed. The data from 2022 helps us understand ADHD in children during the COVID-19 pandemic.

This information aids policymakers, health systems, and public health experts in planning for the care and resources needed to support children dealing with ADHD.